Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Study Exploring the Safety, Tolerability, and Efficacy of a 28 Day Course Followed by an Additional 56 Day Course of Itacitinib in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of LY3009104 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Alternative Dosing Strategy of Ruxolitinib in Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib in Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Relative Bioavailability and Food Effect Study of New Formulations
- Status
- COMPLETED
- Phase
- PHASE1
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Ruxolitinib (INCB018424) in Participants With Primary Myelofibrosis (PMF), Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis (PPV-MF)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase l/II Study of Ruxolitinib for Acute Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)
- Status
- COMPLETED
- Phase
- PHASE3
A Dose-escalation Study in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study in Participants With Rheumatoid Arthritis on Background Methotrexate Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Dose-escalation Study in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
COntrolled MyeloFibrosis Study With ORal JAK Inhibitor Treatment: The COMFORT-I Trial
- Status
- COMPLETED
- Phase
- PHASE3